ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Moffitt To Enhance Information For Brain Tumor Patients.

July 13, 2001

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004

In Brief: John Kovach Succeeds Moertel As Mayo CC Head; DEA Deputy Appointed; New NCAB Member Named

February 7, 1986

In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave

September 21, 1990